It can also reduce the level of urate transporter 1 (mURAT1), inhibit the activity of XOD and increase the excretion of UA to treat hyperuricemia, and can prevent renal insufficiency caused by gout and hyperuricemia in the late stage [101]. Here, SLC22A12 is linked to hyperuricemia.